156 related articles for article (PubMed ID: 2897852)
1. Synergistic cytotoxic effect of tiazofurin and ribavirin in hepatoma cells.
Natsumeda Y; Yamada Y; Yamaji Y; Weber G
Biochem Biophys Res Commun; 1988 May; 153(1):321-7. PubMed ID: 2897852
[TBL] [Abstract][Full Text] [Related]
2. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase.
Yamada Y; Natsumeda Y; Weber G
Biochemistry; 1988 Mar; 27(6):2193-6. PubMed ID: 2897864
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of resistance to tiazofurin in hepatoma 3924A.
Jayaram HN; Pillwein K; Lui MS; Faderan MA; Weber G
Biochem Pharmacol; 1986 Feb; 35(4):587-93. PubMed ID: 2868729
[TBL] [Abstract][Full Text] [Related]
4. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
5. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
Lui MS; Faderan MA; Liepnieks JJ; Natsumeda Y; Olah E; Jayaram HN; Weber G
J Biol Chem; 1984 Apr; 259(8):5078-82. PubMed ID: 6143752
[TBL] [Abstract][Full Text] [Related]
6. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin.
Robins RK; Revankar GR; McKernan PA; Murray BK; Kirsi JJ; North JA
Adv Enzyme Regul; 1985; 24():29-43. PubMed ID: 2872781
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
Weber G; Yamaji Y; Olah E; Natsumeda Y; Jayaram HN; Lapis E; Zhen WN; Prajda N; Hoffman R; Tricot GJ
Adv Enzyme Regul; 1989; 28():335-56. PubMed ID: 2576178
[TBL] [Abstract][Full Text] [Related]
8. Targets and markers of selective action of tiazofurin.
Weber G; Natsumeda Y; Pillwein K
Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
Weber G; Jayaram HN; Lapis E; Natsumeda Y; Yamada Y; Yamaji Y; Tricot GJ; Hoffman R
Adv Enzyme Regul; 1988; 27():405-33. PubMed ID: 2907968
[TBL] [Abstract][Full Text] [Related]
10. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide).
Boritzki TJ; Berry DA; Besserer JA; Cook PD; Fry DW; Leopold WR; Jackson RC
Biochem Pharmacol; 1985 Apr; 34(7):1109-14. PubMed ID: 3985993
[TBL] [Abstract][Full Text] [Related]
12. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
Yamada Y; Goto H; Yoshino M; Ogasawara N
Biochim Biophys Acta; 1990 Mar; 1051(3):209-14. PubMed ID: 1968764
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro studies of Tiazofurin and a selenazole analog.
Streeter DG; Robins RK
Biochem Biophys Res Commun; 1983 Sep; 115(2):544-50. PubMed ID: 6138036
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.
Olah E; Kote Z; Natsumeda Y; Yamaji Y; Jarai G; Lapis E; Financsek I; Weber G
Cancer Biochem Biophys; 1990 Apr; 11(2):107-17. PubMed ID: 1974479
[TBL] [Abstract][Full Text] [Related]
15. Biochemical mechanisms of resistance to tiazofurin.
Jayaram HN
Adv Enzyme Regul; 1985; 24():67-89. PubMed ID: 3835825
[TBL] [Abstract][Full Text] [Related]
16. Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells.
Jayaram HN; Murayama K; Pillwein K; Zhen W; Weber G
Cancer Chemother Pharmacol; 1992; 31(2):93-6. PubMed ID: 1451238
[TBL] [Abstract][Full Text] [Related]
17. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
Sokoloski JA; Blair OC; Sartorelli AC
Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
[TBL] [Abstract][Full Text] [Related]
18. Recovery of the activities of IMP dehydrogenase and GMP synthase after treatment with tiazofurin and acivicin in hepatoma cells in vitro.
Ikegami T; Natsumeda Y; Weber G
Adv Exp Med Biol; 1989; 253B():299-304. PubMed ID: 2575350
[No Abstract] [Full Text] [Related]
19. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
Franchetti P; Grifantini M
Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses.
Huggins JW; Robins RK; Canonico PG
Antimicrob Agents Chemother; 1984 Oct; 26(4):476-80. PubMed ID: 6151377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]